Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Royalty Pharma plc RPRX

Healthcare Biotechnology
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and... see more

Current News (NDAQ:RPRX)

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

GlobeNewswire 7 days ago

Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

GlobeNewswire 7 days ago

Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

GlobeNewswire 7 days ago

Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference

GlobeNewswire 11 days ago

Royalty Pharma Reports Q4 and Full Year 2025 Results

GlobeNewswire February 11, 2026

Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

GlobeNewswire January 20, 2026

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 12, 2026

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire January 11, 2026

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire January 11, 2026
View More News ››

Opinion & Analysis (NDAQ:RPRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RPRX)

Royalty Pharma plc (NASDAQ:RPRX): A Compelling Opportunity i

http://beyondspx.com/2024/08/02/royalty-pharma-plc-nasdaqrprx-a-compelling-opportunity-in-the-rapidly-growing-biopharma-royalty-market/
MikeTester - August 3, 2024

Saw this recommendation this morning

Over 50% return in the past 4 days. This guy probably know something about the stock. FDA monday! http://www.nvest.me/companies/RPRX...
Tracker007 - November 27, 2015

RE:FDA ACCEPTS NDA TODAY

Jk.  From RVX  to BTI to Repros. I bought in on Friday.   I agree.....we just have to sit this out and wait. Gltu
craighenry - June 28, 2015

FDA ACCEPTS NDA TODAY

Just gotta wait now!
Jkj193741 - April 1, 2015

A game changer

Boost testosterone for the first time by a pill rather than a shot, gel, spray etc. at least 2 billion potential market.
Jkj193741 - April 17, 2013

RPRX will probably become the stock to see this ye

Has any person taken a look at the articles being issued? Fascinating information that will assist any investor or trader...  ...
david.smith76 - February 21, 2013
View more Bullboard ››

Allied Critical Metals Inc.

Allied Critical Metals Inc.

Allied Critical Metals (ACM:CSE) is a Canadian-based mining company focused on the expansion and revitalization of its 100 ...
View More »

Podcasts